InvestorsHub Logo
Followers 70
Posts 7727
Boards Moderated 0
Alias Born 01/10/2014

Re: Investor2014 post# 384789

Wednesday, 11/23/2022 12:00:27 PM

Wednesday, November 23, 2022 12:00:27 PM

Post# of 473478
If the FDA was faster in granting Fragile X Orphan Drug Status the trial would have already been in progress.

https://www.anavex.com/post/us-fda-orphan-drug-designation-to-anavex-2-73-blarcamesine-for-the-treatment-of-fragile-x-syndrome

I'll take good planning over hasty actions any day.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News